The Leukemic Presentation of Mantle-cell Lymphoma: Disease Features and Prognostic Factors in 58 Patients

References

• Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, ML., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group". Blood, 84, 1361–1392.
   Google Scholar
• Raffeld, M. and Jaffe, E.S. (1991) "bcl-1, t(11;14), and mantle cell-derived lymphomas". Blood, 78, 259–263.
   PubMed Web of Science ®Google Scholar
• Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W. (eds) (2001) World health organisation classification of tumours. Tumours of haemopoietic and lymphoid tissues., 1st edn. IARC Press: Lyon.
   Google Scholar
• Argatoff, L.H., Connors, J.M., Klasa, R.J., Horsman, D.E. and Gascoyne, RD. (1997) "Mantle cell lymphoma: a clinicopathologic study of 80 cases". Blood, 89, 2067–2078.
   PubMed Web of Science ®Google Scholar
• Barista, I., Romaguera, J.E. and Cabanillas, F. (2001) "Mantle-cell lymphoma". Lancet Oncology, 2, 141 — 148.
   PubMedGoogle Scholar
• Bernard, M., Gressin, R., Lefrere, F., Drenou, B., Branger, B., Caulet-Maugendre, S., et al. (2001) "Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype". Leukemia, 15, 1785 — 1791.
   Google Scholar
• Duggan, M.J., Weisenburger, D.D., Ye, Y.L., Bast, M.A., Pierson, J.L., Linder, J., et al. (1990) "Mantle zone lymphoma. A clinicopathologic study of 22 cases". Cancer, 66, 522— 529.
   PubMed Web of Science ®Google Scholar
• Cuneo, A., Bigoni, R., Rigolin, G.M., Roberti, M.G., Bardi, A., Piva, N., et al. (1999) "Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features". Blood, 93, 1372— 1380.
   Google Scholar
• Greiner, T.C., Moynihan, M.J., Chan, W.C., Lytle, D.M., Pedersen, A., Anderson, J.R., et al. (1996) "p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis". Blood, 87, 4302–4310.
   PubMed Web of Science ®Google Scholar
• Majlis, A., Pugh, W.C., Rodriguez, MA., Benedict, W.F. and Cabanillas, F. (1997) "Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants". Journal of Clinical Oncology, 15, 1664 — 1671.
   Google Scholar
• Norton, A.J., Matthews, J., Pappa, V., Shamash, J., Love, S., Rohatiner, A.Z., et al. (1995) "Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period". Annals of Oncology, 6, 249 — 256.
   PubMed Web of Science ®Google Scholar
• Pittaluga, S., Verhoef, G., Criel, A., Maes, A., Nuyts, J., Boogaerts, M., et al. (1996) "Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma". Leukemia Lymphoma, 21, 115–125.
   PubMed Web of Science ®Google Scholar
• Samaha, H., Dumontet, C., Ketterer, N., Moullet, I., Thieblemont, C., Bouafia, F., et al. (1998) "Mantle cell lymphoma: a retrospective study of 121 cases". Leukemia, 12, 1281–1287.
   PubMed Web of Science ®Google Scholar
• Velders, G.A., Kluin-Nelemans, J.C., De Boer, C.J., Hermans, J., Noordijk, E.M., Schuuring, E., et al. (1996) "Mantle-cell lympho-ma: a population-based clinical study". Journal of Clinical Oncology, 14, 1269 — 1274.
   Google Scholar
• Yatabe, Y., Nakamura, S., Seto, M., Kuroda, H., Kagami, Y., Suzuki, R., et al. (1996) "Clinicopathologic study of PRADI/cyclin DI overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity". American Journal of Surgical Pathology, 20, 1110–1122.
   PubMed Web of Science ®Google Scholar
• Yatabe, Y., Suzuki, R., Tobinai, K., Matsuno, Y., Ichinohasama, R., Okamoto, M., et al. (2000) "Significance of cyclin DI overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin DI-positive MCL and cyclin DI-negative MCL-like B-cell lymphoma". Blood, 95, 2253–2261.
   Google Scholar
• Zoldan, M.C., Inghirami, G., Masuda, Y., Vandekerckhove, F., Raphael, B., Amorosi, E., et al. (1996) "Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome". British Journal of Haematology, 93, 475–486.
   PubMed Web of Science ®Google Scholar
• Bosch, F., Lopez-Guillermo, A., Campo, E., Ribera, J.M., Conde, E., Piris, M.A., et al. (1998) "Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors". Cancer, 82, 567— 575.
   Google Scholar
• Cohen, P.L., Kurtin, P.J., Donovan, K.A. and Hanson, C.A. (1998) "Bone marrow and peripheral blood involvement in mantle cell lymphoma". British Journal of Haematology, 101, 302— 310.
   PubMed Web of Science ®Google Scholar
• Bosch, F., Jares, P., Campo, E., Lopez-Guillermo, A., Piris, M.A., Villamor, N., et al. (1994) "PRAD-1/cyclin DI gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma". Blood, 84, 2726–2732.
   PubMed Web of Science ®Google Scholar
• Bigoni, R., Negrini, M., Veronese, M.L., Cuneo, A., Castoldi, G.L. and Croce, C.M. (1996) "Characterization of t(I 1;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization". Oncogene, 13, 797–802.
   PubMed Web of Science ®Google Scholar
• Elnenaei, M.O., Jadayel, D.M., Matutes, E., Morilla, R., Owusu-Ankomah, K., Atkinson, S., et al. (2001) "Cyclin DI by flow cytometry as a useful tool in the diagnosis of B-cell malignancies". Leukemia Research, 25, 115–123.
   PubMed Web of Science ®Google Scholar
• Matutes, E., Carrara, P., Coignet, L., Brito-Babapulle, V., Villamor, N., Wotherspoon, A., et al. (1999) "FISH analysis for BCL- 1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukaemias". Leukemia, 13, 1721–1726.
   PubMed Web of Science ®Google Scholar
• Ott, MM., Helbing, A., Ott, G., Bartek, J., Fischer, L., Durr, A., et al. (1996) "bcl-1 rearrangement and cyclin DI protein expression in mantle cell lymphoma". Journal of Pathology, 179, 238 — 242.
   PubMed Web of Science ®Google Scholar
• Vaandrager, J.W., Schuuring, E., Zwikstra, E., de Boer, CJ., Kleiverda, K.K., van Krieken, J.H., et al. (1996) "Direct visualiza-tion of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridiza-tion". Blood, 88, 1177 — 1182.
   PubMed Web of Science ®Google Scholar
• Onciu, M., Schlette, E., Medeiros, Li., Abruzzo, L.V., Keating, M. and Lai, R. (2001) "Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities". American Journal of Clinical Pathology, 116, 886–892.
   PubMed Web of Science ®Google Scholar
• Hernandez, L., Fest, T., Cazorla, M., Teruya-Feldstein, J., Bosch, F., Peinado, M.A., et al. (1996) "p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas". Blood, 87, 3351–3359.
   PubMed Web of Science ®Google Scholar
• Ott, G., Kalla, J., Ott, MM., Schryen, B., Katzenberger, T., Muller, J.G., et al. (1997) "Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones". Blood, 89, 1421— 1429.
   PubMed Web of Science ®Google Scholar
• Pinyol, M., Hernandez, L., Cazorla, M., Balbin, M., Jares, P., Fernandez, P.L., et al. (1997) "Deletions and loss of expression of p 16INK4a and p21Wafl genes are associated with aggressive variants of mantle cell lymphomas". Blood, 89, 272–280.
   PubMed Web of Science ®Google Scholar
• Wong, K.F., Chan, J.K., So, J.C. and Yu, P.H. (1999) "Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders". Cancer, 86, 850–857.
   Google Scholar
• Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. and Catovsky, D. (1994) "The immuno-logical profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL". Leukemia, 8, 1640–1645.
   PubMed Web of Science ®Google Scholar
• Moreau, E.J., Matutes, E., A'Hern, R.P., Morilla, A.M., Morilla, R.M., Owusu-Ankomah, K.A., et al. (1997) "Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)". American Journal of Clinical Pathology, 108, 378 — 382.
   Google Scholar
• Jain, P., Giustolisi, G.M., Atkinson, S., Elnenaei, M.O., Morilla, R., Owusu-Ankomah, K., et al. (2002) "Detection of cyclin DI in B cell lymphoproliferative disorders by flow cytometry". Journal of Clinical Pathology, 55, 940–945.
   PubMed Web of Science ®Google Scholar
• De Angeli, C., Gandini, D., Cuneo, A., Moretti, S., Bigoni, R., Roberti, M.G., et al. (2000) "BCL-I rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32)". Haematologica, 85, 913 — 921.
   PubMed Web of Science ®Google Scholar
• De Oliveira, M.S., Jaffe, E.S. and Catovsky, D. (1989) "Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in II cases". Journal of Clinical Pathology, 42, 962–972.
   PubMed Web of Science ®Google Scholar
• Yoong, Y., Kurtin, P.J., Allmer, C., Geyer, S., Habermann, TM., Nagorney, D.M., et al. (2001) "Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma". Leukemia Lymphoma, 42, 1235–1241.
   PubMed Web of Science ®Google Scholar
• Ruchlemer, R., Wotherspoon, AC., Thompson, J.N., Swansbury, J.G., Matutes, E. and Catovsky, D. (2002) "Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia". British Journal of Haematology, 118, 952— 958.
   PubMed Web of Science ®Google Scholar
• Decaudin, D., Bosq, J., Tertian, G., Nedellec, G., Bennaceur, A., Venuat, A.M., et al. (1998) "Phase II trial of fludarabine monopho-sphate in patients with mantle-cell lymphomas". Journal of Clinical Oncology, 16, 579 — 583.
   PubMed Web of Science ®Google Scholar
• Foran, J.M., Rohatiner, A2., Coiffier, B., Barbui, T., Johnson, S.A., Hiddemann, W., et al. (1999) "Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lympho-plasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma". Journal of Clinical Oncology, 17, 546 — 543.
   Google Scholar
• Zinzani, P.L., Magagnoli, M., Moretti, L., Battista, R., Ronconi, F., De Renzo, A., et al. (1999) "Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients". Haematologica, 84, 1002–1006.
   PubMed Web of Science ®Google Scholar
• Cohen, B.J., Moskowitz, C., Straus, D., Noy, A., Hedrick, E. and Zelenetz, A. (2001) "Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma". Leukemia Lymphoma, 42, 1015–1022.
   PubMed Web of Science ®Google Scholar
• Rummel, Mi., Chow, KU., Karakas, T., Jager, E., Mezger, J., von Grunhagen, U., et al. (2002) "Reduced-dose cladribine (2-CdA) plus mitoxantrone is effective in the treatment of mantle-cell and low-grade non-Hodgkin's lymphoma". European Journal of Cancer, 38, 1739 — 1746.
   PubMed Web of Science ®Google Scholar
• Hiddemann, W., Dreyling, M. and Unterhalt, M. (2003) "Ritux-imab plus chemotherapy in follicular and mantle cell lymphomas". Seminars in Oncology, 30, 16–20.
   PubMed Web of Science ®Google Scholar
• Solenthaler, M., Matutes, E., Brito-Babapulle, V., Morilla, R. and Catovsky, D. (2002) "p53 and mdm2 in mantle cell lymphoma in leukemic phase". Haematologica, 87, 1141 — 1150.
   PubMed Web of Science ®Google Scholar
• Orchard, J., Garand, R., Davis, Z., Babbage, G., Sahota, S., Matutes, E., et al. (2003) "A subset of t(I 1;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease". Blood, 101, 4975 — 4981.
   PubMed Web of Science ®Google Scholar